ChemicalBook
Chinese English Japanese Germany Korea

다이페녹시레이트

다이페녹시레이트
다이페녹시레이트 구조식 이미지
카스 번호:
915-30-0
한글명:
다이페녹시레이트
동의어(한글):
다이페녹시레이트
상품명:
Diphenoxylate
동의어(영문):
DIPHENOXYLATE;DiphenoxyleteHCl;Diphenoxyletehydrochloride;HYPPXZBJBPSRLK-UHFFFAOYSA-N;Diphenoxylate hydrochloride CP2000,BP98;ethyl1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate;2,2-diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile;1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-isonipecoticaciethylester;1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecoticacidethylester;1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-isonipecoticacidethylester
CBNumber:
CB3301641
분자식:
C30H32N2O2
포뮬러 무게:
452.59
MOL 파일:
915-30-0.mol

다이페녹시레이트 속성

끓는 점
602.3±55.0 °C(Predicted)
밀도
1.123±0.06 g/cm3(Predicted)
산도 계수 (pKa)
pKa 7.1 (Uncertain)
CAS 데이터베이스
915-30-0(CAS DataBase Reference)
NIST
Diphenoxylate(915-30-0)

안전

위험품 표기 T+
위험 카페고리 넘버 26/27/28-42/43
안전지침서 22-26-45
유해 물질 데이터 915-30-0(Hazardous Substances Data)

다이페녹시레이트 MSDS


Diphenoxylate

다이페녹시레이트 C화학적 특성, 용도, 생산

용도

Antiperistaltic.

Indications

Diphenoxylate (marketed in combination with atropine as Lomotil in the United States) is chemically related to both analgesic and anticholinergic compounds. It is as effective in the treatment of diarrhea as the opium derivatives, and at the doses usually employed, it has a low incidence of central opioid actions. Diphenoxylate is rapidly metabolized by ester hydrolysis to the biologically active metabolite difenoxylic acid.

정의

ChEBI: A piperidinecarboxylate ester that is the ethyl ester of difenoxin.

상표명

Diarphem;Diarsed-neomycin;Diatro;Eldox;Logen;Lomanate;Lomax;Lomotil liquid;Lonox;Protector;Reasec;Saleton;Sedistal.

World Health Organization (WHO)

Diphenoxylate, a derivative of pethidine without analgesic activity, is used in the symptomatic treatment of acute and chronic diarrhoea to reduce intestinal motility. There is no clear evidence that it has any beneficial effect in diminishing fluid losses and it has been associated with central nervous system toxicity, particularly in children, which results in anorexia, nausea and vomiting, headache, drowsiness, confusion, insomnia, dizziness, restlessness, euphoria and depression. The World Health Organization recommends that diphenoxylate should not be used for the management of diarrhoea in children and many countries have since withdrawn products containing this compound indicated for paediatric use. (Reference: (WHORUD) The Rational Use of Drugs, , , 1990)

일반 설명

Diphenoxylate is a weak opioid agonist and isavailable combined with atropine (Lomotil) for use as an antidiarrhealagent. At low doses, the opioid effect is minimal,and the atropine is added to dissuade abuse. One studyfound both codeine and loperamide to be superior to diphenoxylatefor treating chronic diarrhea.83 The manufacturerhas strict dosing guidelines for pediatric use because opioidintoxication and deaths from diphenoxylate have beenreported.

Clinical Use

Lomotil is recommended as adjunctive therapy in the management of diarrhea. It is contraindicated in children under 2 years old and in patients with obstructive jaundice.

부작용

Adverse reactions often caused by the atropine in the preparation include anorexia, nausea, pruritus, dizziness, and numbness of the extremities.

다이페녹시레이트 준비 용품 및 원자재

원자재

준비 용품


다이페녹시레이트 공급 업체

글로벌( 0)공급 업체
공급자 전화 팩스 이메일 국가 제품 수 이점

Copyright 2019 © ChemicalBook. All rights reserved